Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Vindesina")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 100

  • Page / 4
Export

Selection :

  • and

Décès par vindésine intrarachidienne = Death by intrathecal vindesineLa Revue Prescrire. 2007, Vol 27, Num 290, pp 912-912, issn 0247-7750, 1 p.Article

Patients ayant un cancer bronchique non à petites cellules = Patients with a non small cell lung cancerLa Revue Prescrire. 2008, Vol 28, Num DEC, pp 30-35, issn 0247-7750, 6 p., SUPArticle

Administration accidentelle intrathécale de vindésine : à propos de 2 cas mortels = Accidental intrathecal vindesine administration : A report of two casesNISSE, Patrick; CHARPENTIER, Julien; DUBOIS, Francois et al.Thérapie (Paris). 2007, Vol 62, Num 4, pp 360-361, issn 0040-5957, 2 p.Article

Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancerIMAIZUMI, Munehisa.Lung cancer. 2005, Vol 49, Num 1, pp 85-94, issn 0169-5002, 10 p.Article

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancerNEGORO, S; MASUDA, N; TAKADA, Y et al.British journal of cancer. 2003, Vol 88, Num 3, pp 335-341, issn 0007-0920, 7 p.Article

Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan clinical oncology group study 9306SEKINE, Ikuo; NISHIWAKI, Yutaka; ISHIZUKA, Naoki et al.Journal of clinical oncology. 2002, Vol 20, Num 3, pp 797-803, issn 0732-183XArticle

Cancer bronchique non à petites cellules localement évolué : place de la chimioradiothérapie exclusive = Non-small-cell lung cancer: role of definitive chemoradiationMORNEX, F; MARTIN, E; BELLIERE, A et al.Cancer radiothérapie. 2002, Vol 6, pp 117s-124s, issn 1278-3218, SUP1Conference Paper

Adjuvant therapy of malignant melanoma: is there a choice?RETSAS, Spyros.Critical reviews in oncology/hematology. 2001, Vol 40, Num 2, pp 187-193, issn 1040-8428Article

Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma : Results of three consecutive phase II programsTOURANI, Jean Marc; JAILLON-ABRAHAM, Christine; COSCAS, Yvan et al.Acta oncologica (Stockholm). 2000, Vol 39, Num 4, pp 501-508, issn 0284-186XArticle

A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinomaLEBEAU, B; URBAN, T; BRECHOT, J.-M et al.Cancer. 1999, Vol 86, Num 8, pp 1480-1487, issn 0008-543XArticle

Postoperative adjuvant chemotherapy with PVM (cisplatin + Vindesine + Mitomycin c) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer) : A randomized clinical trial. DiscussionWADA, H; MIYAHARA, R; TANAKA, F et al.European journal of cardio-thoracic surgery. 1999, Vol 15, Num 4, pp 438-443, issn 1010-7940Conference Paper

Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC) : a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)BONI, C; SAVOLDI, L; RONDINI, E et al.European journal of cancer (1990). 1998, Vol 34, Num 12, pp 1974-1976, issn 0959-8049Article

Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neckKLOCKER, J; SABITZER, H; RAUNIK, W et al.Cancer letters. 1998, Vol 131, Num 1, pp 113-115, issn 0304-3835Conference Paper

Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine. DiscussionVANSTEENKISTE, Johan; VANDEBROEK, Jean; DEMAN, Rene et al.Lung cancer. 2003, Vol 40, Num 2, pp 191-202, issn 0169-5002, 11 p.Article

Characterization of non-small-cell lung cancer cell lines established before and after chemotherapyKAWAI, Haruyuki; KIURA, Katsuyuki; TABATA, Masahiro et al.Lung cancer. 2002, Vol 35, Num 3, pp 305-314, issn 0169-5002Article

Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cellsKAWAKAMI, Yosuke; HAMA, Seiji; SHIGEMASA, Kazushi et al.Anticancer research. 2001, Vol 21, Num 4A, pp 2537-2545, issn 0250-7005Article

Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugsGROTTKE, Claudia; MANTWILL, Klaus; DIETEL, Manfred et al.International journal of cancer. 2000, Vol 88, Num 4, pp 535-546, issn 0020-7136Article

Association vindésine-méthotrexate dans les carcinomes évolutifs des voies aéro-digestives supérieures = Vindesine-methotrexate combination in upper respiratory tract evolutive carcinomaLOUBEYRE, A; SIMON, P.-G; PIERREFEU, A.-C et al.Journal français d'oto-rhino-laryngologie (1977). 1999, Vol 48, Num 2, pp 97-100, issn 0398-9771Article

Differential in vitro association of vinca alkaloid-induced tubulin spiral filaments into aggregated spiralsVERDIER-PINARD, P; GARES, M; WRIGHT, M et al.Biochemical pharmacology. 1999, Vol 58, Num 6, pp 959-971, issn 0006-2952Article

Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancerSØRENSEN, J. B; BERGMAN, B; NIELSEN, A. L et al.British journal of cancer. 1999, Vol 79, Num 5-6, pp 875-881, issn 0007-0920Article

A 53-year-old patient with unilateral pulmonary infiltrates following a single dose of mitomycin, vindesine and cisplatin chemotherapy for non-small-cell lung cancer : Case discussed at the zurich university hospital, october 15, 1997STRASSER, F; HAILEMARIAM, S; HAUSER, M et al.Respiration (Basel). 1999, Vol 66, Num 6, pp 562-572, issn 0025-7931Article

An experimental trial of ubenimex (Bestatin®) combined with chemotherapy and radiotherapy in nude mice with human lung squamous cell carcinomaKIKUCHI, K; KAINAMI, Y; MOROHASHI, H et al.International journal of immunotherapy. 1999, Vol 15, Num 3-4, pp 107-114, issn 0255-9625Article

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC) : a FONICAP randomized phase II studyBALDINI, E; TIBALDI, C; NOSEDA, M. A et al.British journal of cancer. 1998, Vol 77, Num 12, pp 2367-2370, issn 0007-0920Article

Role of vindesine in induction chemotherapy in locally-advanced non-small-cell lung cancerFISCHER, J. R; DRINGS, P.Journal of cancer research and clinical oncology. 1998, Vol 124, Num 1, pp 4-9, issn 0171-5216Article

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer : A phase III multicentre randomised trialGRIDELLI, C; PERRONE, F; RUSSO, A et al.Annals of oncology. 1996, Vol 7, Num 8, pp 821-826, issn 0923-7534Article

  • Page / 4